HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making
About this episode
Dr Seth Wander discusses the role of biomarker assessment in managing HR-positive metastatic breast cancer.
Dr Seth Wander from Massachusetts General Hospital in Boston discusses the role of biomarker assessment in the management of HR-positive metastatic breast cancer. CME information and select publications here .
More episodes of Oncology Today with Dr Neil Love
- EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
- Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
- Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
- Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
- Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
- Metastatic Bladder Cancer — Rapid Case Review Issue 4
Explore listener stats, chart rankings, contacts and more on the Oncology Today with Dr Neil Love podcast page.